HOOKIPA Pharma GAAP EPS of -$1.10, revenue of $4.7M

• HOOKIPA Pharma press release (NASDAQ:HOOK): Q3 GAAP EPS of -$1.10.
• Revenue of $4.7M (-31.6% Y/Y).
• HOOKIPA’s cash, cash equivalents and restricted cash as of September 30, 2024 was $60.0 million, compared to $117.5 million as of December 31, 2023.

More on HOOKIPA Pharma

• Seeking Alpha’s Quant Rating on HOOKIPA Pharma
• Historical earnings data for HOOKIPA Pharma
• Financial information for HOOKIPA Pharma